热门资讯> 正文

Enanta Pharmaceuticals将普通股发行价定为6500万美元

2025-10-01 12:50

Enanta Pharmaceuticals (NASDAQ:ENTA) has priced its public offering of 6.5M common shares at $10.00 per share for gross proceeds of $65.0M.
The company has granted the underwriters a 30-day option to purchase up to an additional 975,000 shares of common stock at the public offering price.
The offering is expected to close on October 2, 2025.
ENTA --8.2% after hours to $10.98
Source: Press Release

More on Enanta Pharma

Enanta Pharmaceuticals, Inc. (ENTA) RSVHR Study Results Presentation - Slideshow
Enanta Pharmaceuticals, Inc. (ENTA) RSVHR Study Results Call (Transcript)
Enanta: Despite Primary Endpoint Miss Zelicapavir Could Benefit From Trial Design Change
Enanta Pharmaceuticals falls on public offering of common stock
Enanta shares rise despite RSV trial failing to meet main goal

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。